Clinical Trials Logo
  1. Home
  2. Cervical Spondylotic Myelopathy
  3. NCT03296592

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM) — CSM  

Cervical Spondylotic Myelopathy Clinical Trial

Official title:
Predictive Value of Diffusion MRI in Cervical Spondylotic Myelopathy

Clinical Trial Summary

Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.

Clinical Trial Description

CSM is the most common form of spinal cord injury and is the leading cause of progressive disability in patients over the age of 65. A major shortcoming limiting the clinical management of CSM is the lack of quantifiable metrics to 1) base clinical decisions and 2) predict potential for functional recovery following surgical intervention. DBSI MRI will provide imaging biomarkers to more reliably predict a patient's clinical course, response to therapy, and long-term prognosis. Patients who are diagnosed with CSM will have an MRI using the DBSI technology preoperatively and at 24 months. Surgical patients will be assessed with the Neck Disability Index (NDI), Disability of the Arm, Shoulder and Hand (DASH), hand grip dynamometer and Manual Muscle Testing (MMT), the modified Japanese Orthopaedic Association scale (mJOA), and the Major Depression Inventory (MDI), the Short Form-36 (SF-36) and Nurick scoring. A control group of healthy volunteers will have an MRI using the DBSI technology when enrolled and then again between 12-24 months later. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03296592
Study type Observational
Source Washington University School of Medicine
Contact
Status Active, not recruiting
Phase
Start date January 29, 2018
Completion date June 30, 2024
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04952831 - Diffusion MRI in Cervical Spondylotic Myelopathy
Completed NCT00565734 - Surgical Treatment of Cervical Spondylotic Myelopathy Phase 4
Completed NCT00506558 - The CSM Trial: A Multicenter Study Comparing Ventral to Dorsal Surgery for Cervical Spondylotic Myelopathy Phase 3
Recruiting NCT00876603 - Anterior Vs Posterior Procedures for Cervical Spondylotic Myelopathy: Prospective Randomized Clinical Trial N/A
Recruiting NCT06377072 - Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy Phase 3
Enrolling by invitation NCT03513679 - Gait in Adult Patients With Cervical Spondylotic Myelopathy N/A
Completed NCT01257828 - Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) Phase 3
Completed NCT04968054 - Comparison of IONM Between Remimazolam and Propofol N/A
Active, not recruiting NCT04955041 - Effectiveness of T2* MRI in Cervical Spondylotic Myelopathy
Completed NCT01061697 - Pregabalin and Radicular Pain Study (PARPS) Phase 4
Completed NCT03810781 - Postural Stability in Cervical Spinal Myelopathy
Recruiting NCT04936074 - Fusion or no Fusion After Decompression of the Spinal Cord in Patients With Degenerative Cervical Myelopathy N/A
Completed NCT00285337 - Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy N/A
Completed NCT02539394 - Effect of Topical Corticosteroids on Dysphagia in Anterior Cervical Discectomy and Fusion N/A
Recruiting NCT05149404 - The Application of Enhanced Recovery After Surgery Clinical Pathway in Posterior Cervical Spine Surgery